National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

Rights & Permissions

topleft topright

New Vaccine Development: Establishing Priorities: Volume I, Diseases of Importance in the United States (1985)
Board on Population Health and Public Health Practice (BPH)

Citation Manager

. "1. Summary." New Vaccine Development: Establishing Priorities: Volume I, Diseases of Importance in the United States. Washington, DC: The National Academies Press, 1985.

Please select a format:

BibTeX EndNote RefMan


Page
1
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


New Vaccine Development Establishing Priorities, Volume I: Diseases of Importance in the United States

1
Summary

Establishing priorities for vaccine development is complicated by large variations in the morbidity and mortality arising from diseases, the extent of knowledge about relevant pathogens and host responses, the resources and time required for vaccine development, and anticipated vaccine utilization. This report presents a comprehensive model designed at the request of the National Institute of Allergy and Infectious Diseases, National Institutes of Health, to help government decision makers set priorities for accelerated development of vaccines. It can be used to assess new vaccine candidates or to reassess current contenders as additional information becomes available.

The approach suggested uses the same (incomplete) information that could theoretically be used in other methods of decision making. Because the information is incomplete and because the method entails, in some instances, predicting the future, lacunae must be filled by estimates or judgments by experts.

The act of providing a structural framework within which information and judgments are used and combined does not of itself improve the quality of currently available information (although further research to generate new data might be guided by a framework). Nor does it reduce the range of opinion likely to be expressed in predictions, judgments, or estimates (except as issues are more precisely defined).

The committee believes that the system it proposes is the most appropriate for the desired purpose and has implemented it with the best data and estimates that it could develop. It believes that the system would improve the quality of the decision-making process by making it more accessible to evaluation/reconstruction by other decision makers and by facilitating examination of the effect of adopting different assumptions or estimates. However, some cautions and comments are needed to forestall misinterpretation of the power and precision of the method.

In setting out to identify the components on which quantitative information is desirable (but not necessarily available) the system (more than others) exposes areas of ignorance and uncertainty in which expert judgment, by necessity, must be used. Within the proposed approach the use of equations defines the way in which information or estimates are combined (something not always specified in other approaches); this does not imply that the components or the results

Page
1
Front Matter (R1-R14)
1. Summary (1-16)
2. Priority Setting for Health Related Investments: A Review of Methods (17-27)
3. Overview of the Analytic Approach (28-38)
4. Comparison of Disease Burdens and Costs (39-58)
5. Predictions on Vaccine Development (59-66)
6. Assessing the Likely Utilization of New Vaccines (67-91)
7. Calculation and Comparison of the Health Benefits and Costs Associated with Candidate Vaccines (92-120)
8. Additional Issues in the Selection of Priorities for Accelerated Vaccine Development (121-126)
9. Findings, Conclusions, and Recommendations (127-148)
Appendix A: Some Examples of the Application of Project Selection Method (149-152)
Appendix B: Pathogenic Agents for Which Accelerated Vaccine Development Does Not Appear Appropriate (153-170)
Appendix C: Prospects for Immunizing Against Bordetella pertussis (171-182)
Appendix D: Prospects for Immunizing Against Coccidioidomycosis (183-197)
Appendix E: Prospects for Immunizing Against Cytomegalovirus (198-234)
Appendix F: Prospects for Immunizing Against Hemophilus influenzae type b (235-251)
Appendix G: Prospects for Immunizing Against Hepatitis A Virus (252-260)
Appendix H: Prospects for Immunizing Against Hepatitis B Virus (261-279)
Appendix I: Prospects for Immunizing Against Herpes Simplex Viruses 1 and 2 (280-312)
Appendix J: Prospects for Immunizing Against Herpesvirus varicellae (313-341)
Appendix K: Prospects for Immunizing Against Influenza Viruses A and B (342-364)
Appendix L: Prospects for Immunizing Against Neisseria gonorrhoeae (365-384)
Appendix M: Prospects for Immunizing Against Parainfluenza Viruses (385-396)
Appendix N: Prospects for Immunizing Against Respiratory Syncytial Virus (397-409)
Appendix O: Prospects for Immunizing Against Rotavirus (410-423)
Appendix P: Prospects for Immunizing Against Streptococcus group B (424-439)
Appendix Q: Questionnaire for Assessing Morbidity-Mortality Trade-Offs (440-443)
Appendix R: Technical Notes (444-444)
Appendix S: Biographical Notes on Committee Members (445-449)
Appendix T: Additional Sources of Advice to the Committee (450-452)
Index (453-458)

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 1

OCR for page 2

OCR for page 3

OCR for page 4

OCR for page 5

OCR for page 6

OCR for page 7

OCR for page 8

OCR for page 9

OCR for page 10

OCR for page 11

OCR for page 12

OCR for page 13

OCR for page 14

OCR for page 15

OCR for page 16